OREANDA-NEWS. DuPont (NYSE: DD), a science company that brings world-class, innovative products, materials, and services to the global marketplace, today announced second-quarter 2016 GAAP earnings of $1.16 per share and operating earnings2 of $1.24 per share.  Prior year GAAP and operating earnings2 were $1.06 and $1.09 per share, respectively.  Refer to Schedule B for details of significant items.

Second-quarter 2016 sales totaled $7.1 billion, down slightly versus prior year as volume growth of 2 percent was more than offset by pressure from local price, currency and portfolio. 

"Our continued focus on our plan delivered strong results. Solid execution enabled volume growth of 2 percent, and we expanded operating margins across all reportable segments.  Cost savings, mix enrichment from new technologies and lower product costs contributed to the margin expansion. Continued progress on our cost savings program keeps us on track to reach $1 billion on a run-rate basis by year-end," said Ed Breen, chair and CEO of DuPont. "We are pleased with the overwhelming vote of approval the merger received from our shareholders. We are preparing to hit the ground running immediately after closing, which we continue to expect later this year as we work closely with regulators in all relevant jurisdictions. We look forward to standing up three strong businesses and enhancing our ability to offer innovative, value-added solutions and increased choice to our customers."

Global Consolidated Net Sales – 2nd Quarter

   

Three Months Ended

               
   

June 30, 2016

 

Percent Change Due to:

       

%

 

Local Price and

         

Portfolio /

   

$

 

Change

 

Product Mix**

 

Currency

 

Volume**

 

Other

                         

(Dollars in millions)

                       

     U.S. & Canada

 

$    3,550

 

(1)

 

(1)

 

-

 

1

 

(1)

     EMEA *

 

1,418

 

(4)

 

-

 

-

 

(3)

 

(1)

     Asia Pacific 

 

1,557

 

3

 

(2)

 

(2)

 

6

 

1

     Latin America

 

536

 

(1)

 

(1)

 

(6)

 

7

 

(1)

                         

Total Consolidated Sales

$    7,061

 

(1)

 

(1)

 

(1)

 

2

 

(1)

                         

*  Europe, Middle East & Africa

                   

** Organic sales growth is defined as the sum of local price and product mix and volume.

   

Segment Net Sales – 2nd Quarter

   

Three Months Ended

               
   

June 30, 2016

 

Percent Change Due to:

       

%

 

Local Price and

         

Portfolio /

   

$

 

Change

 

Product Mix

 

Currency

 

Volume

 

Other

(Dollars in millions)

                       

Agriculture

 

$    3,218

 

-

 

-

 

(2)

 

3

 

(1)

Electronics & Communications

494

 

(6)

 

(2)

 

-

 

(4)

 

-

Industrial Biosciences

 

355

 

(1)

 

-

 

(1)

 

-

 

-

Nutrition & Health

 

835

 

1

 

(1)

 

(1)

 

3

 

-

Performance Materials

 

1,335

 

-

 

(4)

 

-

 

4

 

-

Protection Solutions

 

786

 

(2)

 

-

 

-

 

(2)

 

-

Other

 

38

                   

Consolidated Net Sales

 

7,061

 

(1)

 

(1)

 

(1)

 

2

 

(1)

Operating Earnings(1) – 2nd Quarter

         

Change vs. 2015

(Dollars in millions)

2Q16

 

2Q15

 

$

 

%

Agriculture

$        865

 

$        772

 

$           93

 

12%

Electronics & Communications

93

 

89

 

4

 

4%

Industrial Biosciences

62

 

50

 

12

 

24%

Nutrition & Health

130

 

100

 

30

 

30%

Performance Materials

325

 

301

 

24

 

8%

Protection Solutions

188

 

181

 

7

 

4%

Other

(50)

 

(46)

 

(4)

 

-9%

Total segment operating earnings (2) 

1,613

 

1,447

 

166

 

11%

               

Exchange gains (losses) (2),(3)

(15)

 

11

 

(26)

 

nm

Corporate expenses (2) 

(83)

 

(148)

 

65

 

-44%

Interest expense(2)

(93)

 

(74)

 

(19)

 

26%

Operating earnings before income taxes (1)

1,422

 

1,236

 

186

 

15%

Provision for income taxes on operating earnings (1)

(325)

 

(237)

 

(88)

   

Less: Net income attributable to noncontrolling interests 

4

 

5

 

(1)

   

Operating earnings (1)

$      1,093

 

$        994

 

$           99

 

10%

               

Operating earnings per share (1)

$        1.24

 

$       1.09

 

$        0.15

 

14%

GAAP earnings per share

$        1.16

 

$       1.06

 

$        0.10

 

9%

               

(1) See Schedules A, C and D for reconciliations of non-GAAP measures.

       
               

(2) See Schedules B and C for listing of significant items.

           
               

(3) See Schedule D for additional information on exchange gains and losses.

       

The following is a summary of business results for each of the company's reportable segments comparing the second quarter with the prior year, unless otherwise noted.

Agriculture – Operating earnings of $865 million increased $93 million, or 12 percent, on lower product costs, higher volumes and cost savings, partially offset by a $36 million negative currency impact.  Increased corn seed and insecticide volumes were partially offset by lower soybean volumes.  Operating margins expanded by 290 basis points.  Excluding the impact of currency, operating earnings increased 17 percent.

Electronics & Communications– Operating earnings of $93 million increased $4 million, or 4 percent, as cost savings and lower product costs more than offset lower demand in consumer electronics and a $1 million negative impact from currency. Operating margins expanded by 200 basis points. Excluding the impact of currency, operating earnings increased 6 percent.

Industrial Biosciences – Operating earnings of $62 million increased $12 million, or 24 percent, on cost savings partially offset by a $3 million negative impact from currency.  Sales growth in bioactives due to benefits from new product introductions in home and personal care and increased demand in biomaterials were offset by lower volume in CleanTech.  Operating margins expanded by about 350 basis points. Excluding the impact of currency, operating earnings increased 30 percent.

Nutrition & Health – Operating earnings of $130 million increased $30 million, or 30 percent, on cost savings and broad-based volume growth led by probiotics and specialty proteins. Operating margins expanded by about 350 basis points. Excluding a $3 million negative impact from currency, operating earnings increased 33 percent.

Performance Materials – Operating earnings of $325 million increased $24 million, or 8 percent. Cost savings, increased demand in automotive markets (primarily in China and North America) and increased volumes for ethylene due to a prior year unplanned ethylene outage, were partially offset by a $16 million negative impact from currency, as well as costs associated with a contractual claim. Operating margins expanded by over 180 basis points. Excluding the impact of currency, operating earnings increased 13 percent.

Protection Solutions – Operating earnings of $188 million increased $7 million, or 4 percent, driven by lower product costs and cost savings, partially offset by lower volumes and a $4 million negative currency impact. Operating margins expanded by about 150 basis points. Volume declines in Nomex® thermal-resistant fiber and Kevlar® high-strength material were driven by weakness in the oil and gas industry and delays in military spending. Excluding the impact of currency, operating earnings increased 6 percent.

2016 Outlook

The company now expects full-year 2016 GAAP earnings to be in the range of $2.70 to $2.75 per share and operating earnings2 to be in the range of $3.15 to $3.20 per share, an increase of $0.10 per share to the low-end of its previously communicated range. The estimated negative currency impact for full-year 2016 is now expected to be about $0.15 per share.  The company continues to expect a benefit of $0.64 per share from the 2016 global cost savings and restructuring plan and a headwind from a higher base tax rate in 2016 of about $0.10 per share.  The company's full-year 2016 GAAP earnings includes an expected charge of about $0.45 per share for transaction costs associated with the planned merger with Dow. For third-quarter 2016, the company expects operating earnings per share to be 50 percent higher than the prior year.

E.I. du Pont de Nemours and Company

Consolidated Income Statements

(Dollars in millions, except per share amounts)

 
 

SCHEDULE A

             
 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

2016

 

2015

 

2016

 

2015

Net sales

$

7,061

   

$

7,121

   

$

14,466

   

$

14,958

 

Cost of goods sold

3,990

   

4,103

   

8,232

   

8,619

 

Other operating charges (1)

143

   

174

   

328

   

322

 

Selling, general and administrative expenses (1)

1,211

   

1,274

   

2,339

   

2,494

 

Research and development expense

432

   

495

   

850

   

974

 

Other income, net (1)

(51)

   

(255)

   

(423)

   

(454)

 

Interest expense (1)

93

   

94

   

185

   

178

 

Employee separation / asset related charges, net (1)

(90)

   

2

   

(13)

   

40

 
               

Income from continuing operations before income taxes

1,333

   

1,234

   

2,968

   

2,785

 

Provision for income taxes on continuing operations (1)

306

   

260

   

712

   

790

 

Income from continuing operations after income taxes

1,027

   

974

   

2,256

   

1,995

 

Loss from discontinued operations after income taxes

(3)

   

(29)

   

   

(15)

 
               

Net income

1,024

   

945

   

2,256

   

1,980

 
               

Less:  Net income attributable to noncontrolling interests

4

   

5

   

10

   

9

 
               

Net income attributable to DuPont

$

1,020

   

$

940

   

$

2,246

   

$

1,971

 
               

Basic earnings (loss) per share of common stock:

             

Basic earnings per share of common stock from continuing operations

$

1.17

   

$

1.07

   

$

2.56

   

$

2.19

 

Basic loss per share of common stock from discontinued operations

   

(0.03)

   

   

(0.02)

 

Basic earnings per share of common stock (2)

$

1.16

   

$

1.04

   

$

2.56

   

$

2.17

 
               

Diluted earnings (loss) per share of common stock:

             

Diluted earnings per share of common stock from continuing operations

$

1.16

   

$

1.06

   

$

2.55

   

$

2.17

 

Diluted loss per share of common stock from discontinued operations

   

(0.03)

   

   

(0.02)

 

Diluted earnings per share of common stock (2)

$

1.16

   

$

1.03

   

$

2.55

   

$

2.15

 
               

Dividends per share of common stock

$

0.38

   

$

0.49

   

$

0.76

   

$

0.96

 
               

Average number of shares outstanding used in earnings (loss) per share
(EPS) calculation:

             

  Basic

875,013,000

   

905,761,000

   

874,269,000

   

906,296,000

 

  Diluted

879,179,000

   

911,681,000

   

878,214,000

   

912,748,000

 
               

Reconciliation of Non-GAAP Measures

       

Summary of Earnings Comparison

           
 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

2016

 

2015

 

% Change

 

2016

 

2015

 

% Change

Income from continuing operations after income taxes (GAAP)

$

1,027

   

$

974

   

5%

 

$

2,256

   

$

1,995

   

13%

Less: Significant items benefit (charge) included in income from continuing operations after income taxes (per Schedule B)

19

   

32

       

179

   

(25)

     

Non-operating pension/OPEB costs included in income from continuing
operations after income taxes (3)

(89)

   

(57)

       

(135)

   

(136)

     

Net income attributable to noncontrolling interest from continuing operations

4

   

5

       

10

   

9

     

Operating earnings (Non-GAAP) (4)

$

1,093

   

$

994

   

10%

 

$

2,202

   

$

2,147

   

3%

                       

Earnings per share from continuing operations (GAAP)

$

1.16

   

$

1.06

   

9%

 

$

2.55

   

$

2.17

   

18%

Less: Significant items benefit (charge) included in EPS (per Schedule B)

0.02

   

0.04

       

0.20

   

(0.02)

     

Non-operating pension/OPEB costs included in EPS (3)

(0.10)

   

(0.07)

       

(0.15)

   

(0.16)

     

Operating earnings per share (Non-GAAP) (4)

$

1.24

   

$

1.09

   

14%

 

$

2.50

   

$

2.35

   

6%

                       


 

E.I. du Pont de Nemours and Company

Condensed Consolidated Balance Sheets

(Dollars in millions, except per share amounts)

 
 

SCHEDULE A (continued)

   
   

June 30,

2016

 

December 31,

2015

Assets

       

Current assets

       

Cash and cash equivalents

 

$

4,411

   

$

5,300

 

Marketable securities

 

742

   

906

 

Accounts and notes receivable, net

 

7,656

   

4,643

 

Inventories

 

4,756

   

6,140

 

Prepaid expenses

 

526

   

398

 

Total current assets

 

18,091

   

17,387

 

Property, plant and equipment, net of accumulated depreciation

   (June 30, 2016- $14,699; December 31, 2015 - $14,346)

 

9,624

   

9,784

 

Goodwill

 

4,245

   

4,248

 

Other intangible assets

 

3,967

   

4,144

 

Investment in affiliates

 

695

   

688

 

Deferred income taxes

 

4,474

   

3,799

 

Other assets

 

1,170

   

1,116

 

Total

 

$

42,266

   

$

41,166

 
         

Liabilities and Equity

       

Current liabilities

       

Accounts payable

 

$

2,244

   

$

3,398

 

Short-term borrowings and capital lease obligations

 

2,295

   

1,165

 

Income taxes

 

164

   

173

 

Other accrued liabilities

 

3,675

   

5,580

 

Total current liabilities

 

8,378

   

10,316

 

Long-term borrowings and capital lease obligations

 

8,119

   

7,642

 

Other liabilities

 

14,818

   

12,591

 

Deferred income taxes

 

410

   

417

 

Total liabilities

 

31,725

   

30,966

 
         

Commitments and contingent liabilities

       
         

Stockholders' equity

       

Preferred stock

 

237

   

237

 

Common stock, $0.30 par value; 1,800,000,000 shares authorized;

   Issued at June 30, 2016 - 961,258,000; December 31, 2015 - 958,388,000

 

288

   

288

 

Additional paid-in capital

 

11,212

   

11,081

 

Reinvested earnings

 

16,084

   

14,510

 

Accumulated other comprehensive loss

 

(10,757)

   

(9,396)

 

Common stock held in treasury, at cost (87,041,000 shares at June 30, 2016 and December 31, 2015)

 

(6,727)

   

(6,727)

 

Total DuPont stockholders' equity

 

10,337

   

9,993

 

Noncontrolling interests

 

204

   

207

 

Total equity

 

10,541

   

10,200

 

Total

 

$

42,266

   

$

41,166

 

E.I. du Pont de Nemours and Company

Condensed Consolidated Statement of Cash Flows

(Dollars in millions)

 
 

SCHEDULE A (continued)

 
 

Six Months Ended

June 30,

 

2016

 

2015

Total Company

     
       

Net income

$

2,256

   

$

1,980

 

Adjustments to reconcile net income to cash used for operating activities:

     

Depreciation

473

   

615

 

Amortization of intangible assets

226

   

257

 

Net periodic pension benefit cost

320

   

294

 

Contributions to pension plans

(237)

   

(204)

 

Gain on sale of businesses and other assets

(385)

   

(22)

 

Other operating activities - net

378

   

59

 

Change in operating assets and liabilities - net

(4,534)

   

(5,024)

 

Cash used for operating activities

(1,503)

   

(2,045)

 

Investing activities

     

Purchases of property, plant and equipment

(507)

   

(938)

 

Investments in affiliates

(2)

   

(50)

 

Proceeds (payments) from sale of businesses and other assets - net

212

   

(29)

 

Net decrease (increase) in short-term financial instruments

174

   

(422)

 

Foreign currency exchange contract settlements

(280)

   

443

 

Other investing activities - net

(15)

   

13

 

Cash used for investing activities

(418)

   

(983)

 

Financing activities

     

Dividends paid to stockholders

(669)

   

(875)

 

Net increase in borrowings

1,632

   

2,110

 

Repurchase of common stock

   

(353)

 

Proceeds from exercise of stock options

88

   

201

 

Other financing activities - net

(14)

   

(81)

 

Cash provided by financing activities

1,037

   

1,002

 

Effect of exchange rate changes on cash

(5)

   

(138)

 

Decrease in cash and cash equivalents

(889)

   

(2,164)

 

Cash and cash equivalents at beginning of period

5,300

   

6,910

 

Cash and cash equivalents at end of period

$

4,411

   

$

4,746

 
       

Reconciliation of Non-GAAP Measure

     

Calculation of Free Cash Flow - Total Company

     
 

Six Months Ended

June 30,

 

2016

 

2015

Cash used for operating activities (GAAP)

$

(1,503)

   

$

(2,045)

 

Purchases of property, plant and equipment

(507)

   

(938)

 

Free cash flow (Non-GAAP)

$

(2,010)

   

$

(2,983)

 
       

(1) See Schedule B for detail of significant items.

(2) The sum of the individual earnings per share amounts from continuing operations and discontinued operations may not equal the total company earnings per share amounts due to rounding.

(3) Year to date June 30, 2015 non-operating pension/OPEB costs includes an after-tax exchange loss on foreign pension balances of $23.

(4) Operating earnings and operating earnings per share are defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs. Non-operating pension/OPEB costs includes all of the components of net periodic benefit cost from continuing operations with the exception of the service cost component.

E.I. du Pont de Nemours and Company

Schedule of Significant Items from Continuing Operations

(Dollars in millions, except per share amounts)

 
 

SCHEDULE B

                   

SIGNIFICANT ITEMS

       
                         
   

Pre-tax

 

After-tax

 

($ Per Share)

   

2016

 

2015

 

2016

 

2015

 

2016

 

2015

1st Quarter

                     

Transaction costs (1)

$

(24)

   

$

(12)

   

$

(21)

   

$

(11)

   

$

(0.02)

   

$

(0.01)

 

Customer claims adjustment/recovery (2)

23

   

35

   

15

   

22

   

0.02

   

0.02

 

Gain on sale of entity (3)

369

   

   

214

   

   

0.24

   

 

Restructuring charges, net (4)

(77)

   

   

(48)

   

   

(0.06)

   

 

Asset impairment charge (5)

   

(37)

   

   

(30)

   

   

(0.03)

 

Ukraine devaluation (6)

   

(40)

   

   

(38)

   

   

(0.04)

 

1st Quarter - Total

$

291

   

$

(54)

   

$

160

   

$

(57)

   

$

0.18

   

$

(0.06)

 
                         

2nd Quarter

                     

Transaction costs (1)

$

(76)

   

$

(25)

   

$

(59)

   

$

(38)

   

$

(0.07)

   

$

(0.04)

 

Customer claims recovery (2)

30

   

   

19

   

   

0.02

   

 

Restructuring adjustments / charges (4)

90

   

(2)

   

59

   

(2)

   

0.07

   

 

Litigation settlement (7)

   

112

   

   

72

   

   

0.08

 

2nd Quarter - Total

$

44

   

$

85

   

$

19

   

$

32

   

$

0.02

   

$

0.04

 
                         

Year-to-date Total (8)

$

335

   

$

31

   

$

179

   

$

(25)

   

$

0.20

   

$

(0.02)

 

E.I. du Pont de Nemours and Company

Schedule of Significant Items from Continuing Operations

(Dollars in millions, except per share amounts)

 

(1)

Second quarter and first quarter 2016 included charges of $(76) and $(24), respectively, recorded in selling, general and administrative expenses related to costs associated with the planned merger with the Dow Chemical Company and related activities.

   
 

Second quarter 2015 included charges of $(25) associated with transaction costs related to the separation of the Performance Chemicals segment consisting of $(5) recorded in other operating charges and $(20) recorded in interest expense.  Second quarter 2015 also includes a tax charge of $(17) due to a state tax rate change associated with the separation. First quarter 2015 included charges of $(12) recorded in other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment.

   

(2)

The company recorded insurance recoveries of $30 and $35 in the second quarter 2016 and first quarter 2015, respectively, in other operating charges for recovery of costs for customer claims related to the use of the Agriculture's segment Imprelis® herbicide.

First quarter 2016 included a benefit of $23 in other operating charges for reduction in accrual for customer claims related to the use of the Imprelis® herbicide.

   

(3)

First quarter 2016 included a gain of $369 recorded in other income, net associated with the sale of the DuPont (Shenzhen) Manufacturing Limited entity, which held certain buildings and other assets.  The gain is reflected as a Corporate item.

   

(4)

Second quarter 2016 included a $90 benefit recorded in employee separation/asset related charges, net associated with the 2016 Global Cost Savings and Restructuring Program.  This benefit was primarily due to the reduction in severance and related benefit costs due to the elimination of positions at a lower cost than expected.  The benefit impacted segment earnings as follows: Agriculture - $5, Electronics & Communications - $8, Industrial Biosciences - $3, Nutrition & Health - $12, Performance Materials - $9, Protection Solutions - $7, and Corporate expenses - $46.

   
 

First quarter 2016 included a $(2) restructuring charge recorded in employee separation/asset related charges, net associated with the 2016 Global Cost Savings and Restructuring Program.  This charge was primarily due to the identification of additional projects in certain segments, offset by reduction in severance and related benefit costs.  The net charge impacted segment earnings as follows: Agriculture - $(21), Electronics & Communications - $7, Industrial Biosciences - $1, Nutrition & Health - $1, Performance Materials - $(4), Protection Solutions - $3, Other - $(3), and Corporate expenses - $14.

   
 

First quarter 2016 included a $(75) restructuring charge recorded in employee separation/asset related charges, net related to the decision to not re-start the Agriculture segment's insecticide manufacturing facility at the La Porte site located in La Porte, Texas.  The charge included $(41) of asset related charges, $(18) of contract termination costs, and $(16) of employee severance and related benefit costs.

   
 

Second quarter 2015 included a $(2) restructuring charge recorded in employee separation/asset related charges, net associated with the 2014 restructuring program. These adjustments were primarily due to the identification of additional projects in certain segments, offset by lower than estimated individual severance costs and workforce reductions achieved through non-severance programs. The net reduction impacted segment earnings for the three months ended as follows: Agriculture - $(4), Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Materials - $(2), Protection Solutions - $1, and Other - $(3).

   

(5)

During first quarter of 2015, a $(37) pre-tax impairment charge was recorded in employee separation / asset related charges, net for a cost basis investment within the Other segment.  The assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions.  One of the primary investors has communicated they would not fund the revised operating plan of the investee.  As a result, the carrying value of our 6% equity investment in this venture exceeds its fair value.

   

(6)

First quarter 2015 included a charge of $(40) in other income, net associated with remeasuring the company's Ukrainian hryvnia net monetary assets. Ukraine's central bank adopted a decision to no longer set the indicative hryvnia exchange rate. The hryvnia became a free-floating exchange rate and lost approximately a third of its value through the quarter.

   

(7)

Second quarter 2015 included a gain of $112, net of legal expenses, recorded in other income, net related to the company's settlement of a legal claim.  This matter relates to the Protection Solutions segment.

   

(8)

Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.

   

E.I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)

 
 

SCHEDULE C

               
   

Three Months Ended

June 30,

 

Six Months Ended

June 30,

SEGMENT NET SALES (1)

 

2016

 

2015

 

2016

 

2015

Agriculture

 

$

3,218

   

$

3,218

   

$

7,004

   

$

7,155

 

Electronics & Communications

 

494

   

528

   

946

   

1,045

 

Industrial Biosciences

 

355

   

357

   

707

   

707

 

Nutrition & Health

 

835

   

826

   

1,636

   

1,639

 

Performance Materials

 

1,335

   

1,338

   

2,584

   

2,719

 

Protection Solutions

 

786

   

806

   

1,515

   

1,596

 

Other

 

38

   

48

   

74

   

97

 

Consolidated net sales

 

$

7,061

   

$

7,121

   

$

14,466

   

$

14,958

 
                 
   

Three Months Ended

June 30,

 

Six Months Ended

June 30,

SEGMENT OPERATING EARNINGS (1)

 

2016

 

2015

 

2016

 

2015

Agriculture

 

$

865

   

$

772

   

$

1,966

   

$

1,910

 

Electronics & Communications

 

93

   

89

   

152

   

168

 

Industrial Biosciences

 

62

   

50

   

125

   

104

 

Nutrition & Health

 

130

   

100

   

234

   

186

 

Performance Materials

 

325

   

301

   

598

   

618

 

Protection Solutions

 

188

   

181

   

364

   

348

 

Other

 

(50)

   

(46)

   

(109)

   

(77)

 

Total segment operating earnings

 

1,613

   

1,447

   

3,330

   

3,257

 

Corporate expenses

 

(83)

   

(148)

   

(169)

   

(302)

 

Interest expense

 

(93)

   

(74)

   

(185)

   

(158)

 

Operating earnings before income taxes and exchange
(losses) gains

 

1,437

   

1,225

   

2,976

   

2,797

 

Net exchange (losses) gains (2)

 

(15)

   

11

   

(136)

   

153

 

Operating earnings before income taxes (Non-GAAP)

 

$

1,422

   

$

1,236

   

$

2,840

   

$

2,950

 

Non-operating pension/OPEB costs (3)

 

(133)

   

(87)

   

(207)

   

(196)

 

Total significant items before income taxes

 

44

   

85

   

335

   

31

 

Income from continuing operations before income taxes (GAAP)

 

$

1,333

   

$

1,234

   

$

2,968

   

$

2,785

 
                 
   

Three Months Ended

June 30,

 

Six Months Ended

June 30,

SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (1)(4)

 

2016

 

2015

 

2016

 

2015

Agriculture

 

$

35

   

$

(4)

   

$

(38)

   

$

31

 

Electronics & Communications

 

8

   

11

   

15

   

11

 

Industrial Biosciences

 

3

   

(1)

   

4

   

(1)

 

Nutrition & Health

 

12

   

(4)

   

13

   

(4)

 

Performance Materials

 

9

   

(2)

   

5

   

(2)

 

Protection Solutions

 

7

   

113

   

10

   

113

 

Other

 

   

(3)

   

(3)

   

(40)

 

Total significant items by segment

 

74

   

110

   

6

   

108

 

Corporate expenses

 

(30)

   

(5)

   

329

   

(17)

 

Interest expense

 

   

(20)

   

   

(20)

 

Net exchange gains (losses)

 

   

   

   

(40)

 

Total significant items before income taxes

 

$

44

   

$

85

   

$

335

   

$

31

 


 

E.I. du Pont de Nemours and Company

Consolidated Segment Information

(Dollars in millions)

 
 

SCHEDULE C (continued)

                   

Reconciliation of Segment Operating Earnings and Operating Earnings EPS excluding the impact of currency (Non-GAAP)

Segment operating earnings and operating earnings per share excluding the impact of currency assumes current operating earnings results using foreign currency exchange rates in effect for the comparable prior-year period.

                     
   

Three Months Ended

June 30, 2015

 

Three Months Ended

June 30, 2016

   

Segment Operating Earnings

 

Segment Operating Earnings

 

Impact of Currency

 

Segment Operating Earnings Excluding Currency

 

% Change

Agriculture

 

$

772

   

$

865

   

$

(36)

   

$

901

   

17%

Electronics & Communications

 

89

   

93

   

(1)

   

94

   

6

Industrial Biosciences

 

50

   

62

   

(3)

   

65

   

30

Nutrition & Health

 

100

   

130

   

(3)

   

133

   

33

Performance Materials

 

301

   

325

   

(16)

   

341

   

13

Protection Solutions

 

181

   

188

   

(4)

   

192

   

6

Other

 

(46)

   

(50)

   

   

(50)

   

(9)

Total segment operating earnings

 

$

1,447

   

$

1,613

   

$

(63)

   

$

1,676

   

16%

                     
   

Three Months Ended

June 30, 2015

 

Three Months Ended

June 30, 2016

   

Operating Earnings
per share
(Non-GAAP) (5)

 

Operating Earnings
per share
(Non-GAAP) (5)

 

 Impact of Currency

 

Operating Earnings
per share excluding
currency
(Non-GAAP) (5)

 

 % Change

Operating earnings per share (Non-GAAP) (5)

 

$

1.09

   

$

1.24

   

$

(0.05)

   

$

1.29

   

18%

                     

Corporate Expenses

       

The reconciliation below reflects GAAP corporate expenses excluding significant items.

     
   

Three Months Ended

June 30,

   

2016

 

2015

Corporate expenses (GAAP)

 

$

113

   

$

153

 

Significant items (4)

 

30

   

5

 

Corporate expenses (Non-GAAP)

 

$

83

   

$

148

 
         

(1)  Segment operating earnings is defined as income (loss) from continuing operations before income taxes excluding significant pre-tax benefits (charges), non-operating pension/OPEB costs, exchange gains (losses), corporate expenses and interest. DuPont Sustainable Solutions, previously within the company's Safety & Protection segment (now Protection Solutions) was comprised of two business units: Clean Technologies (CleanTech) and Consulting Solutions.  Effective January 1, 2016, the CleanTech business is reported in the Industrial Biosciences segment and the Consulting Solutions business unit is reported within Other.  Reclassifications of prior year data have been made to conform to current year classifications.

(2)  See Schedule D for additional information on exchange gains and losses.  Year to date June 30, 2015 exchange gains, on an operating earnings basis (Non-GAAP), excludes the impact of a $23 exchange loss on non-operating pension.

(3) Year to date June 30, 2015, non-operating pension/OPEB costs includes a $23 exchange loss on foreign pension balances.

(4)  See Schedule B for detail of significant items.

(5) See Schedule A for reconciliation of operating earnings per share.


 

E.I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions, except per share amounts)

     
       
       

SCHEDULE D

                 

Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements

               
     

Three Months Ended

June 30,

 

Six Months Ended

June 30,

     

2016

 

2015

 

2016

 

2015

Income from continuing operations before income taxes (GAAP)

 

$

1,333

   

$

1,234

   

$

2,968

   

$

2,785

 

Add: Significant items benefit before income taxes

 

(44)

   

(85)

   

(335)

   

(31)

 

Add: Non-operating pension/OPEB costs (1)

 

133

   

87

   

207

   

196

 

Operating earnings before income taxes (Non-GAAP)

 

$

1,422

   

$

1,236

   

$

2,840

   

$

2,950

 

Less: Net income attributable to noncontrolling interests from
continuing operations

 

4

   

5

   

10

   

9

 

Add:  Interest expense (2)

   

93

   

74

   

185

   

158

 

Adjusted EBIT from operating earnings (Non-GAAP)

 

1,511

   

1,305

   

3,015

   

3,099

 

Add: Depreciation and amortization

 

339

   

362

   

699

   

745

 

Adjusted EBITDA from operating earnings (Non-GAAP)

 

$

1,850

   

$

1,667

   

$

3,714

   

$

3,844

 

Reconciliation of Operating Costs to Consolidated Income Statement Line Items

GAAP operating costs is defined as other operating charges, selling, general and administrative expenses, and research and development costs. The reconciliation below reflects operating costs excluding significant items and non-operating pension/OPEB costs.

       
 

Three months ended June 30, 2016

 

Three months ended June 30, 2015

 

As Reported (GAAP)

Less: Significant Items (2)

Less: Non-
Operating
Pension/
OPEB Costs

 

(Non-GAAP)

 

As Reported (GAAP)

Less: Significant Items (2)

Less: Non-
Operating
Pension/
OPEB Costs

 

(Non-GAAP)

Other operating charges

$

143

 

$

(30)

 

$

 

$

173

   

$

174

 

$

5

 

$

 

$

169

 

Selling, general and administrative
expenses

1,211

 

76

 

53

 

1,082

   

1,274

 

 

35

 

1,239

 

Research and development expense

432

 

 

20

 

412

   

495

 

 

13

 

482

 

Total

$

1,786

 

$

46

 

$

73

 

$

1,667

   

$

1,943

 

$

5

 

$

48

 

$

1,890

 
   

Reconciliation of Operating Earnings Per Share (EPS) Outlook

 

The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings excluding significant items and non-operating pension/OPEB costs.

 
             
     

Year Ended December 31,

 
     

2016 Outlook

 

2015 Actual

 

Operating EPS (Non-GAAP)

   

$  3.15 - 3.20

   

$

2.77

   
             

Significant items (2)

           

Transaction costs (3)

   

(0.45)

   

(0.07)

   

Gain on sale of entity

   

0.24

   

   

Restructuring adjustments / charges

   

0.01

   

(0.58)

   

Customer claims adjustment/recovery

   

0.04

   

0.23

   

Litigation settlement

   

   

0.10

   

Asset impairment charge

   

   

(0.03)

   

Ukraine devaluation

   

   

(0.04)

   
             

Non-operating pension/OPEB costs - estimate (4)

   

(0.29)

   

(0.29)

   
             

EPS from continuing operations (GAAP)

   

$  2.70 - 2.75

   

$

2.09

   
                                                                     

E.I. du Pont de Nemours and Company

Reconciliation of Non-GAAP Measures

(Dollars in millions, except per share amounts)

 
 

SCHEDULE D (continued)

         
                 

Exchange Gains/Losses on Operating Earnings (2)

     

The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in other income, net and the related tax impact is recorded in provision for (benefit from) income taxes on the Consolidated Income Statements.

                 
   

Three Months Ended

June 30,

 

Six Months Ended

June 30,

   

2016

 

2015

 

2016

 

2015

Subsidiary Monetary Position Gain (Loss)

               

Pre-tax exchange gains (losses)

 

$

146

   

$

29

   

$

179

   

$

(87)

 

Local tax (expenses) benefits

 

(60)

   

25

   

(47)

   

(93)

 

Net after-tax impact from subsidiary exchange gains (losses)

 

$

86

   

$

54

   

$

132

   

$

(180)

 
                 

Hedging Program Gain (Loss)

               

Pre-tax exchange (losses) gains

 

$

(161)

   

$

(18)

   

$

(315)

   

$

240

 

Tax benefits (expenses)

 

58

   

6

   

113

   

(87)

 

Net after-tax impact from hedging program exchange (losses) gains

 

$

(103)

   

$

(12)

   

$

(202)

   

$

153

 
                 

Total Exchange Gain (Loss)

               

Pre-tax exchange (losses) gains (5)

 

$

(15)

   

$

11

   

$

(136)

   

$

153

 

Tax (expenses) benefits

 

(2)

   

31

   

66

   

(180)

 

Net after-tax exchange (losses) gains

 

$

(17)

   

$

42

   

$

(70)

   

$

(27)

 
                 

As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."

                 

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate

       

Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), as defined above, significant items and non-operating pension/OPEB costs.

                 
   

Three Months Ended

June 30,

 

Six Months Ended

June 30,

   

2016

 

2015

 

2016

 

2015

Income from continuing operations before income taxes (GAAP)

 

$

1,333

   

$

1,234

   

$

2,968

   

$

2,785

 

Add:   Significant items - benefit (2)

 

(44)

   

(85)

   

(335)

   

(31)

 

           Non-operating pension/OPEB costs (1)

 

133

   

87

   

207

   

196

 

Less:  Net exchange (losses) gains (5)

 

(15)

   

11

   

(136)

   

153

 

Income from continuing operations before income taxes, significant items,

    exchange (losses) gains, and non-operating pension/OPEB costs (Non-GAAP)

$

1,437

   

$

1,225

   

$

2,976

   

$

2,797

 
                 

Provision for income taxes on continuing operations (GAAP)

 

$

306

   

$

260

   

$

712

   

$

790

 

Add:  Tax expenses on significant items

 

(25)

   

(53)

   

(156)

   

(56)

 

          Tax benefits on non-operating pension/OPEB costs

 

44

   

30

   

72

   

60

 

          Tax (expenses) benefits on exchange gains/losses

 

(2)

   

31

   

66

   

(180)

 

Provision for income taxes on continuing earnings, excluding exchange gains (losses) (Non-GAAP)

$

323

   

$

268

   

$

694

   

$

614

 
                 

Effective income tax rate (GAAP)

 

23.0%

   

21.1%

   

24.0%

   

28.4%

 

Significant items and non-operating pension/OPEB costs effect

 

(0.1)%

   

(1.9)%

   

(1.9)%

   

(1.5)%

 

Tax rate, from continuing operations before significant items and non-operating pension/OPEB costs

22.9%

   

19.2%

   

22.1%

   

26.9%

 

Exchange (losses) gains effect

 

(0.4)%

   

2.7%

   

1.2%

   

(4.9)%

 

Base income tax rate from continuing operations (Non-GAAP)

 

22.5%

   

21.9%

   

23.3%

   

22.0%

 
                 

(1) Year to date June 30, 2015, non-operating pension/OPEB costs includes a $23 exchange loss on foreign pension balances.

(2) See Schedule B for detail of significant items.

(3) The 2016 outlook for significant items includes the current estimate for full year 2016 transaction costs associated with the planned merger with The Dow Chemical Company and related activities.

(4) The 2016 estimate for non-operating pension/OPEB costs does not include additional settlements and curtailments expected during the remainder of the year as a result of actions associated with the 2016 global cost savings and restructuring plan.

(5) Year to date June 30, 2015 exchange gains, on an operating earnings basis (Non-GAAP), excludes a $23 exchange loss on non-operating pension.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2016-results-300303650.html

SOURCE DuPont

Media Contact: Dan Turner, 302-996-8372, daniel.a.turner@dupont.com; or Investor Contact: 302-774-4994